Oct 2026· Frontiers in Aging Neuroscience· Vol 18· 0 citations· 41 references
Medicine
TL;DR
The association between BD and increased dementia risk was observed across the examined subgroups and substantial between-study heterogeneity and the limited evidence available for specific dementia subtypes warrant cautious interpretation of the pooled estimates.
Abstract
Background Bipolar disorder (BD) is associated with cognitive impairment and an increased risk of dementia; however, the magnitude of this association and subtype-specific risk patterns remain unclear. This systematic review and meta-analysis quantified the associations between BD and the risks of all-cause dementia, Alzheimer’s disease (AD), and vascular dementia (VaD), and explored potential sources of between-study heterogeneity. Methods PubMed, Embase, the Cochrane Library, and Web of Science were searched from inception to September 15, 2026. Eligible cohort and case–control studies reported adjusted effect estimates for the association between BD and dementia. Hazard ratios and odds ratios were converted to risk ratios (RRs) prior to quantitative synthesis. Random- or fixed-effects models were applied according to heterogeneity. Leave-one-out sensitivity analyses, Egger’s test for publication bias, and subgroup analyses stratified by follow-up duration, sex, age at BD onset, and study design were conducted. Results Eleven studies involving 1,536,508 participants and 90,864 all-cause dementia cases were included. BD was associated with an increased risk of all-cause dementia (RR = 3.55, 95% CI 2.48–5.07; I2 = 98.7%), AD (RR = 5.08, 95% CI 1.87–13.84; I2 = 97.2%), and VaD (RR = 4.33, 95% CI 3.06–6.13; I2 = 71.7%). Estimates for all-cause dementia and VaD were robust in sensitivity analyses, whereas the AD estimate was sensitive to the exclusion of individual studies and should therefore be interpreted cautiously. The association between BD and increased dementia risk was observed across the examined subgroups. Formal tests for subgroup differences showed no statistically significant differences according to sex or age at BD onset. Conclusion BD is associated with an increased risk of all-cause dementia, AD, and VaD. However, substantial between-study heterogeneity and the limited evidence available for specific dementia subtypes warrant cautious interpretation of the pooled estimates. Further high-quality longitudinal studies are needed to clarify the factors underlying heterogeneity and subtype-specific associations. Systematic review registration https://www.crd.york.ac.uk/prospero/, identifier [CRD420261395626].
Lithium exposure was consistently associated with reduced dementia risk, and the magnitude, consistency, and biological plausibility support lithium as a promising candidate for dementia prevention research.
Lorenzo Campedelli, Andrea Cicoli, M. Lastretti et al.· Journal of Alzheimer's Disea...· 0 citations
Background: Dementia affects over 55 million individuals worldwide, with projections indicating a substantial increase in prevalence in the coming decades. Statins are widely prescribed for cardiovascular prevention and have been proposed to exert pleiotropic effects, including anti-inflammatory and neuroprotective mec...
Rafael da Silva Clemente, Mariana Minante Khalil, Eric Batista Ferreira· ANPAbstract_CBN26· 0 citations
INTRODUCTION
Bipolar disorder (BD) is a chronic psychiatric illness characterized by recurrent manic and depressive episodes, affecting 2% of the global population. It is associated with premature mortality, including cardiovascular disease (CVD)-related mortality. Although clinically important, the absolute burden and...
Fernando Daibert de Souza Motta, Matheus de Lima Ruffini, Amanda Cunha Ritter et al.· Acta Psychiatrica Scandinavi...· 0 citations
Dementia risk assessment scales show variable predictive performance across scores, baseline age, and follow-up duration, and may be useful for dementia risk stratification in clinical practice, and may be useful for dementia risk stratification in clinical practice.
Tímea Lázár, Eszter Radics, M. Engh et al.· GeroScience· 0 citations
Abstract Introduction Anxiety is among the earliest and most common neuropsychiatric symptoms in cognitive impairment. Emerging evidence suggests that anxiety may elevate the risk of cognitive decline in mild cognitive impairment (MCI). This systematic review and meta-analysis was performed to quantitatively synthesize...
D. Fresnais, Brynjar Fure· Dementia and Geriatric Cogni...· 0 citations
This systematic review evaluated longitudinal evidence on the association between MBI and incident dementia, including conversion rates, dementia subtypes, domain-specific risk patterns, and biomarker correlates, finding MBI seems to represent a clinically meaningful syndrome that identifies individuals at elevated ris...
K. L. M. Sassi, A. Thomson, Vanessa M. Young et al.· Journal of Alzheimer's Disea...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.